In this state of advanced insulin resistance, the decrease in insulin lowers PI3K/AKT signaling and increases FoxO1 activity which impairs PDX1-mediated β-cell growth further reducing insulin secretion and contributing to T2D pathogenesis. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.